Investors
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Shareholders and financial analysts should address inquiries concerning Novo Nordisk and its business operations to the Investor Relations Officers. The first day after the end of each quarter until the day of the release of the quarterly report are quiet periods with no broad business discussions with investors and financial analysts.
Investors
Share price
{{priceData.date}} {{priceData.time}}